bluebird bio Inc (BLUE)
0.348
+0.05
(+16.82%)
USD |
NASDAQ |
Nov 22, 16:00
0.34
-0.01
(-2.30%)
After-Hours: 20:00
bluebird bio Market Cap: 67.67M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 57.92M |
| November 20, 2024 | 58.92M |
| November 19, 2024 | 59.32M |
| November 18, 2024 | 64.75M |
| November 15, 2024 | 62.38M |
| November 14, 2024 | 70.51M |
| November 13, 2024 | 73.17M |
| November 12, 2024 | 75.95M |
| November 11, 2024 | 78.59M |
| November 08, 2024 | 78.67M |
| November 07, 2024 | 74.10M |
| November 06, 2024 | 85.21M |
| November 05, 2024 | 87.73M |
| November 04, 2024 | 89.78M |
| November 01, 2024 | 90.37M |
| October 31, 2024 | 89.98M |
| October 30, 2024 | 94.79M |
| October 29, 2024 | 95.37M |
| October 28, 2024 | 95.91M |
| October 25, 2024 | 93.12M |
| October 24, 2024 | 96.78M |
| October 23, 2024 | 99.42M |
| October 22, 2024 | 98.06M |
| October 21, 2024 | 96.34M |
| October 18, 2024 | 95.17M |
| Date | Value |
|---|---|
| October 17, 2024 | 94.34M |
| October 16, 2024 | 93.43M |
| October 15, 2024 | 93.31M |
| October 14, 2024 | 97.60M |
| October 11, 2024 | 98.12M |
| October 10, 2024 | 95.93M |
| October 09, 2024 | 95.89M |
| October 08, 2024 | 94.48M |
| October 07, 2024 | 100.95M |
| October 04, 2024 | 110.53M |
| October 03, 2024 | 100.45M |
| October 02, 2024 | 94.48M |
| October 01, 2024 | 91.28M |
| September 30, 2024 | 100.74M |
| September 27, 2024 | 97.81M |
| September 26, 2024 | 96.47M |
| September 25, 2024 | 92.69M |
| September 24, 2024 | 96.96M |
| September 23, 2024 | 94.80M |
| September 20, 2024 | 91.18M |
| September 19, 2024 | 95.41M |
| September 18, 2024 | 95.99M |
| September 17, 2024 | 96.98M |
| September 16, 2024 | 112.02M |
| September 13, 2024 | 117.47M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
57.92M
Minimum
Nov 21 2024
2.700B
Maximum
Jan 17 2020
807.30M
Average
522.93M
Median
Market Cap Benchmarks
| AIM ImmunoTech Inc | 13.38M |
| Perspective Therapeutics Inc | 235.88M |
| Protalix BioTherapeutics Inc | 125.18M |
| Electromed Inc | 250.95M |
| Armata Pharmaceuticals Inc | 81.41M |
Market Cap Related Metrics
| PS Ratio | 1.145 |
| PEG Ratio | -0.0016 |
| Price | 0.348 |
| Earnings Yield | -514.4% |
| PEGY Ratio | -0.0016 |